Wealthfront Advisers LLC Purchases Shares of 35,873 Integer Holdings Co. (NYSE:ITGR)

Wealthfront Advisers LLC acquired a new position in shares of Integer Holdings Co. (NYSE:ITGR) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 35,873 shares of the medical equipment provider’s stock, valued at approximately $4,754,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Blue Trust Inc. lifted its stake in shares of Integer by 4.4% during the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock worth $220,000 after buying an additional 71 shares during the last quarter. Arizona State Retirement System raised its holdings in Integer by 0.9% in the 4th quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider’s stock valued at $1,290,000 after acquiring an additional 84 shares during the period. HighTower Advisors LLC lifted its position in Integer by 0.8% during the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock worth $1,579,000 after acquiring an additional 90 shares during the last quarter. Norden Group LLC boosted its holdings in shares of Integer by 7.0% during the fourth quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider’s stock worth $221,000 after acquiring an additional 109 shares during the period. Finally, State of New Jersey Common Pension Fund D grew its position in shares of Integer by 0.9% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 15,722 shares of the medical equipment provider’s stock valued at $2,083,000 after purchasing an additional 140 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Price Performance

ITGR stock opened at $118.41 on Friday. The company’s 50-day moving average price is $134.43 and its two-hundred day moving average price is $132.75. The firm has a market cap of $3.98 billion, a P/E ratio of 35.24, a P/E/G ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a 12 month low of $107.11 and a 12 month high of $146.36.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. On average, analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ITGR has been the subject of several research reports. Wells Fargo & Company reissued an “overweight” rating and set a $160.00 price target on shares of Integer in a report on Tuesday, December 3rd. Benchmark increased their price objective on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Citigroup boosted their target price on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Truist Financial raised their price target on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Finally, KeyCorp lifted their price objective on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $147.67.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.